Search results for "vaccine" in Articles / App Notes
Article
Track-and-Trace Progress Benefits Supply-Chain Security Efforts
Since the COVID-19 pandemic struck, there has been little news of serialization breakthroughs, as manufacturers and their supply partners have focused on getting new therapeutics and vaccines to patie…
Article
Process Development: 2020 Reflections and 2021 Possibilities
Last year in particular reenforced the need to reapproach optimization and flexibility for all bioprocesses, as well as emphasized the importance of life-saving products such as vaccines.
To shed …
Article
Scalable Viral Vector Manufacturing
As cost pressure in the biopharma and vaccine industry increase globally, the choice of manufacturing technology is becoming increasingly important. The manufacturing processes and technologies are cr…
Article
Achieving Efficient Adenovirus Upstream Production
Adenovirus is one of the most frequently used viral vectors in the development of therapeutic vaccines and vaccines against infectious diseases. Adenovirus has also been explored as a viral vector f…
Article
Biopharmaceutical Market in Asia: Q&A with Günter Jagschies, Strategic Customer Relations Leader, Cytiva
…iotherapeutic drugs on the high end of the price range as well as even to the much cheaper class of vaccines. Korea, Japan, and Singapore, in particular, have a well-established biopharma industry wi…
Article
SEC in the Modern Downstream Purification Process
Governmental pressures to localize vaccine manufacturing in the country of origin also make SEC applications more attractive. The low technical threshold and ease of process development will streamlin…
Article
Pharma Investments Reflect Key Industry Trends
GSK is selling its oncology business to Novartis and buying Novartis’ vaccines business (excluding influenza vaccines), and the two companies are combining their over-the-counter businesses.
In Ma…
Article
Operational Excellence: More Than Just Process Improvement
For a vaccine maker, a simultaneous two-site initiative saved a total of $50 million across two facilities. Such transformations can yield a multiplicity of operational, organizational, and financial …
Article
Scaling Up Novel Therapies
“Many processes rely on the culture of adherent cells for producing a range of biological molecules, including viral vaccines, viral vectors for gene therapy, and oncolytic viruses. Producing these th…
Article
Manufacturing of Viral Vectors
Viral vectors are also explored for use in gene and cell therapy and as the basis for prophylactic and therapeutic vaccines. In gene therapy, viral vectors can be used for the delivery of functional g…